Cargando…
Intranasal immunization with a helper-dependent adenoviral vector expressing the codon-optimized fusion glycoprotein of human respiratory syncytial virus elicits protective immunity in BALB/c mice
BACKGROUND: Human respiratory syncytial virus (RSV) is a serious pediatric pathogen of the lower respiratory tract. Currently, there is no clinically approved vaccine against RSV infection. Recent studies have shown that helper-dependent adenoviral (HDAd) vectors may represent effective and safe vac...
Autores principales: | Fu, Yuan-Hui, He, Jin-Sheng, Qiao, Wei, Jiao, Yue-Ying, Hua, Ying, Zhang, Ying, Peng, Xiang-Lei, Hong, Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3685604/ https://www.ncbi.nlm.nih.gov/pubmed/23742026 http://dx.doi.org/10.1186/1743-422X-10-183 |
Ejemplares similares
-
The protective immunity induced by intranasally inoculated serotype 63 chimpanzee adenovirus vector expressing human respiratory syncytial virus prefusion fusion glycoprotein in BALB/c mice
por: Huang, Lei, et al.
Publicado: (2022) -
Differential Biodistribution of Adenoviral-Vectored Vaccine Following Intranasal and Endotracheal Deliveries Leads to Different Immune Outcomes
por: Jeyanathan, Vidthiya, et al.
Publicado: (2022) -
Editorial: Adenoviral Infection and Immunity, and Adenoviral Vectors for Gene Therapy Applications
por: Zhang, Qiwei, et al.
Publicado: (2022) -
Subretinal gene delivery using helper-dependent adenoviral vectors
por: Wu, Linda, et al.
Publicado: (2011) -
Feasibility of Applying Helper-Dependent Adenoviral Vectors for Cancer Immunotherapy
por: Farzad, Lisa M., et al.
Publicado: (2014)